Pre-Existing Reactivity and Risk Mitigation
Authored by: Jim McNally, Ph.D., Senior Principal Scientist, Biotherapeutics Research, Pfizer, Inc.
* - required fields
View All Sponsors
View Media Partners
View 2013 Attendee List
Reducing and Monitoring Bioassay Variability
2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions